If you own Johnson & Johnson (NYSE: JNJ) stock, there's a really good chance that you do so because of its dividend. The healthcare giant is a longtime favorite for income investors, in large part due to its sterling track record of 56 consecutive years of dividend increases.But if you really prioritize dividend payments, Johnson & Johnson isn't the best choice.